In the year since we launched this blog quite a lot has happened here at Corindus and throughout the industry. For starters, we are pleased to announce that there has been tremendous growth in the number of CorPath Robotic Angioplasties performed at top hospitals across the United States as they implement robotics programs in their catheterization labs.
Additionally, recent studies have shed light on the occupational hazards of interventional cardiology, which include cancer, cataracts, and chronic back and joint pain. Physicians who are performing robotic-assisted PCI are benefiting from an improved working environment that is radiation protected and free from heavy lead apparel. At Corindus, our promise is to deliver this safer working environment to physicians without compromising patient care. For us, that means putting robotic precision in the hands of heart experts to potentially improve clinical outcomes.
One recent study published in the Journal of Invasive Cardiology showed strong trends that suggest robotic-assisted PCI is not only safe and effective, but compares favorably to traditional manual PCI. The study, which was completed at NewYork Presbyterian Hospital, compared 40 robotic-assisted PCIs performed during the CorPath PRECISE clinical trial to the next 80 consecutive procedures done manually that met the inclusion criteria of the clinical trial. The study demonstrated trends towards reduction in fluoroscopy time, radiation dose, and contrast volume for the patient.
We are committed to continued clinical research to demonstrate the value and applicability of CorPath Robotic Angioplasty in PCI procedures and eventually other applications within the vascular space. The PRECISION registry launched since the introduction of this blog, and patient enrollment continues to accelerate. Internally, our research and development is constantly working to improve the CorPath System and to build a plan for the future of vascular robotics.
We have also participated in several conferences throughout the year including Transcatheter Cardiovascular Therapeutics (TCT), the American College of Cardiology’s (ACC) Annual Conference and, most recently, the Society for Cardiovascular Angiography and Interventions (SCAI) Annual Scientific Sessions. Here, physicians get to experience CorPath hands-on with a simulator, listen to talks on robotic angioplasty from their peers, and attend symposia on implementing robotics programs.
You can find presentations given by leading interventional cardiologists at these conferences as well as case reviews of complex robotic-assisted PCI by visiting the Corindus website. There, you will also be able to find details on past and current clinical trials, view testimonials by physicians on the benefits of CorPath, and sign up for a hands-on demonstration of CorPath at one of our upcoming events.
We hope you will continue to follow us as we work to bring robotic precision and physician safety to hospitals across the United States. Stay tuned for upcoming posts where we will highlight the top interventional cardiology news of 2014 and a sneak peek at what’s in store for Corindus at the upcoming TCT conference!